Suppr超能文献

Susac 综合征继发于 SARS-CoV-2 抗原双重暴露后的旁中心性急性中-黄斑病变。

Paracentral acute middle maculopathy in Susac syndrome after dual exposure to SARS-CoV-2 antigen.

机构信息

Department of Ophthalmology and Visual Sciences, Federal University of Sao Paulo, Sao Paulo, Brazil.

Neurology Division, Universidade de São Paulo, Sao Paulo, Brazil.

出版信息

BMJ Case Rep. 2022 May 10;15(5):e247159. doi: 10.1136/bcr-2021-247159.

Abstract

We report a case of Susac syndrome after SARS-CoV-2 infection and subsequent vaccination that presented with meningitis and retinal microembolisation in the form of paracentral acute middle maculopathy (PAMM). After presenting with headache, fever and myalgia followed by scotomata, a woman in her 50s was hospitalised for meningitis; she had had mild COVID-19 infection 2 months prior to admission, having received the first vaccine dose 1 month prior to the neurological manifestation. Eye fundus examination and optical coherence tomography were suggestive of PAMM. D-dimer levels and erythrocyte sedimentation rate were elevated. Before infectious investigation results were available, she was started on empirical antibiotic and antiviral treatment. Having ruled out infectious causes, she was started on high-dose prednisolone. After 1 month, there was partial resolution of retinal lesions. This case highlights that exposure to SARS-CoV-2 antigen may be related to this rare syndrome; treatment with steroids may improve central and retinal impairment.

摘要

我们报告了一例 SARS-CoV-2 感染及后续接种疫苗后发生的 Susac 综合征病例,该病例表现为脑膜脑炎和视网膜微栓塞,呈旁中心性急性中黄斑病变(PAMM)。一位 50 多岁的女性因头痛、发热和肌痛伴随后发性盲而住院,她在入院前 2 个月感染了轻度 COVID-19,在神经表现前 1 个月接种了第一剂疫苗。眼底检查和光学相干断层扫描提示 PAMM。D-二聚体水平和红细胞沉降率升高。在获得感染性调查结果之前,她开始接受经验性抗生素和抗病毒治疗。在排除感染性病因后,开始给予大剂量泼尼松龙治疗。1 个月后,视网膜病变部分缓解。该病例强调,SARS-CoV-2 抗原的暴露可能与这种罕见的综合征有关;类固醇治疗可能改善中枢和视网膜损伤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90f2/9092144/dddc6f95e338/bcr-2021-247159f01.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验